By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Foundation Medicine has raised $10 million toward a $20.5 million financing round, the company disclosed in a regulatory filing with the US Securities and Exchange Commission on Tuesday.

A company spokesman declined to comment on the filing or provide information on investors in the round. According to the SEC document, one investor has participated in the equity round so far.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.